Gilead Sciences Inc. GILD, +0.66% shares ticked higher in the extended session Thursday after the biotech drug maker topped Wall Street estimates for earnings but not for revenue.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,